Close Menu

Is Judge Robert Sweet's decision to overturn Myriad's BRCA1 and BRCA2 gene patents the end of gene patenting as we know it? Genomics Law Report's John Conley and Dan Vorhaus broke down the case and its implications in their blog, saying it is an important decision, but it is equally important not to overstate things.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.